Logan Capital Management Inc. cut its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 9.9% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,089 shares of the company’s stock after selling 10,521 shares during the period. Logan Capital Management Inc.’s holdings in Procter & Gamble were worth $15,309,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in the company. Kingstone Capital Partners Texas LLC lifted its holdings in Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Northern Trust Corp raised its position in Procter & Gamble by 0.8% in the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after purchasing an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD lifted its stake in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Procter & Gamble by 3.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Procter & Gamble by 6.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Wall Street Analysts Forecast Growth
PG has been the topic of a number of recent analyst reports. Bank of America decreased their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Barclays decreased their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. UBS Group dropped their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Evercore ISI restated an “in-line” rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, Raymond James Financial lowered their price target on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $171.53.
Procter & Gamble Stock Performance
NYSE:PG opened at $151.62 on Tuesday. Procter & Gamble Company has a 52 week low of $146.96 and a 52 week high of $180.43. The company has a fifty day simple moving average of $154.58 and a two-hundred day simple moving average of $158.31. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.45. The company has a market cap of $354.85 billion, a price-to-earnings ratio of 22.13, a price-to-earnings-growth ratio of 4.05 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter & Gamble had a return on equity of 32.51% and a net margin of 19.74%.The business had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. During the same period last year, the firm earned $1.93 earnings per share. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s payout ratio is currently 61.75%.
Insider Transactions at Procter & Gamble
In related news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the transaction, the insider owned 12,616 shares in the company, valued at $1,920,533.68. The trade was a 3.74% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares of the company’s stock, valued at $7,139,434.77. This trade represents a 7.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 over the last quarter. Insiders own 0.20% of the company’s stock.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- What Are Earnings Reports?
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- How to trade penny stocks: A step-by-step guide
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- What Are Treasury Bonds?
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
